LIBRETTO-432: A placebo-controlled phase 3 study of adjuvant selpercatinib in stage IB-IIIA RET fusion-positive NSCLC Meeting Abstract
| Authors: | Goldman, J.; Besse, B.; Wu, Y.; Yang, J. C.; Paz-Ares, L.; Drilon, A.; Johnson, M.; Xia, M.; Chao, B. H.; Tsuboi, M. |
| Abstract Title: | LIBRETTO-432: A placebo-controlled phase 3 study of adjuvant selpercatinib in stage IB-IIIA RET fusion-positive NSCLC |
| Meeting Title: | 2021 World Conference on Lung Cancer |
| Keywords: | adjuvant; selpercatinib; ret fusion-positive |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2021 Sep 8-14 |
| Meeting Location: | Virtual event |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-10-01 |
| Start Page: | S975 |
| End Page: | S976 |
| Language: | English |
| ACCESSION: | WOS:000709606500262 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.08.262 |
| Notes: | Meeting Abstract: P01.01 -- Source: Wos |
